Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

14.42
+0.38002.71%
Post-market: 14.420.00000.00%18:39 EDT
Volume:1.40M
Turnover:20.42M
Market Cap:1.98B
PE:-2.80
High:14.97
Open:14.23
Low:14.22
Close:14.04
Loading ...
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 10, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Major Issues Report

Form 8-K - Current report
Mar 16, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2024

Major Issues Report

Form 8-K - Current report
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities